Matthew J. Ellis

Duke University

Public scientific profile · Unclaimed

Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.

Top expertise

PARP inhibition in cancer therapy
Solid evidence · 1 supporting paper · latest 2026
Microtubule and mitosis dynamics
Solid evidence · 1 supporting paper · latest 2026
DNA Repair Mechanisms
Supporting evidence · 1 supporting paper · latest 2026
Cancer Treatment and Pharmacology
Supporting evidence · 1 supporting paper · latest 2026
Cancer-related Molecular Pathways
Supporting evidence · 1 supporting paper · latest 2026
Breast Cancer Treatment Studies
Supporting evidence · 1 supporting paper · latest 2026

LIG1 Loss in TP53 -mutant Triple-Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP–ATR Inhibitor Combinations
2026DOI
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancer.
2026DOI

Affiliation evidence only — not confirmed current employment.

Source: ScienceWe Extractor · retrieved 2026-09-27